drugset / Trial / NCT02630888

Efficacy of Memantine add-on in the Treatment of Bipolar Disorder (Type I) Nonresponders or Partial Responders Patients

NCT02630888

Phase 2 Unknown 44 enrolled University of Sao Paulo
RandomizedParallel-groupTriple-blindTreatment

Summary

The main goal of this study is evaluate the efficacy of memantine association on the treatment with a previous combination of two drugs, including quetiapine with lithium or quetiapine with aripiprazole in young patients with bipolar disorder type 1 non-responders or partial responders to that combination of drugs and evaluate the impact of this association at the cognitive functioning of the patients.

Timeline

Start
2014-08
Primary completion
2020-04
Completion
2020-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Memantine Unknown 30 mg

Indications